For research use only. Not for therapeutic Use.
Ibazocine(Cat No.:I029027)is a synthetic compound that acts as a selective dopamine receptor agonist, specifically targeting the D2 dopamine receptor. It is primarily studied in the context of neuropharmacology for its potential therapeutic effects on neurodegenerative disorders and psychiatric conditions, such as Parkinson’s disease and schizophrenia. By stimulating dopamine receptors, ibazocine may help modulate dopaminergic signaling, which is disrupted in these diseases. Its ability to selectively activate specific dopamine receptors offers the potential for more targeted treatments with fewer side effects compared to traditional dopamine agonists, although its clinical applications are still under investigation.
Catalog Number | I029027 |
CAS Number | 57653-28-8 |
Synonyms | Ibazocine |
Molecular Formula | C20H29NO |
Purity | 98% |
Solubility | To be determined |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 1,13,13-trimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol |
InChI | InChI=1S/C20H29NO/c1-14(2)8-10-21-11-9-20(5)17-13-16(22)7-6-15(17)12-18(21)19(20,3)4/h6-8,13,18,22H,9-12H2,1-5H3 |
InChIKey | CFUQBFQTFMOZBK-UHFFFAOYSA-N |
SMILES | CC(=CCN1CCC2(C3=C(CC1C2(C)C)C=CC(=C3)O)C)C |